Insmed
INSM
100 hedge funds and large institutions have $998M invested in Insmed in 2017 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 31 reducing their positions, and 14 closing their positions.
31% more capital invested
Capital invested by funds: $765M → $998M (+$233M)
29% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 14
3% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 31
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less funds holding
Funds holding: 101 → 100 (-1)
1.5% less ownership
Funds ownership: 93.41% → 91.9% (-1.5%)
76% less call options, than puts
Call options by funds: $5.44M | Put options by funds: $22.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$72.2M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$5.53M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.65M |
| 4 |
JGC
J. Goldman & Co
New York
|
+$3.41M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$7.57M |
| 2 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$4.55M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.28M |
| 4 |
NC
Nexthera Capital
New York
|
-$4.26M |
| 5 |
SOMRS
State of Michigan Retirement System
Lansing,
Michigan
|
-$3.97M |
INSM Hedge Fund Activity: Q1 2017 in Review
100 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q1 2017, worth a combined $998M — up 31% from $765M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new INSM positions and 14 closed out — a net gain of 4 holders — while 32 added to existing stakes and 31 trimmed.
The largest buyer was BlackRock, adding an estimated $72.2M. The largest seller was OrbiMed, cutting an estimated $7.57M.
- 100 institutional investors held Insmed (INSM) as of Q1 2017, down from 101 in Q4 2016.
- Funds reported $998M of Insmed stock for Q1 2017, up 31% quarter-over-quarter.
- 18 funds opened new Insmed positions in Q1 2017 and 14 closed out, a net change of +4 holders.
- The largest Insmed buyer in Q1 2017 was BlackRock, an estimated $72.2M added.
- The largest Insmed seller in Q1 2017 was OrbiMed, an estimated $7.57M sold.
Based on aggregated 13F filings for Q1 2017.